Quantitative Improvement in Brain Tumor MRI Through Structured Reporting (BT-RADS)

Rationale and Objectives Determine the objective benefits of structured reporting of brain tumors through Brain tumor-RADS (BT-RADS) by analyzing discrete quantifiable metrics of the reports themselves. Materials and Methods Following Institutional Review Board approval, post-treatment glioma reports were acquired from two matched 3-month time periods for pre- and postimplementation of BT-RADS. The reports were analyzed for presence of history words, such as “Avastin” and “methylguanine-DNA methyltransferase,” as well as hedge words, such as “Possibly” and “Likely.” The word counts of the total report and of the impression section were also assessed, as well as whether or not the report contained addenda. Results In total, 211 pre-BT-RADS and 172 post-BT-RADS reports were analyzed. Post-BT-RADS reports demonstrated greater reporting of history words, including “Avastin” (7.6% vs. 20.9%, p Conclusion Following implementation of BT-RADS, glioma reports demonstrated greater consistency and completeness of clinical history, less ambiguity, and more conciseness.